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1.  Supporting Schemes 
 
 
Scheme S1. a) (i) TMSSPh, ZnI2, DCM; (ii) TBAF, THF; (iii) Ac2O, DMAP, pyr (55%, three 
steps). b) NIS-AgOTf, 3-azido-1-propanol, MeCN, -20 oC to 25 oC, 64%. c) (i) Pd/C, H2, EtOAc; 
(ii) aq. NaHCO3, acryloyl chloride, dioxane, 0 oC to 25 oC (57%, two steps). d) NaOMe, MeOH, 
90%. 
 
 
 
Scheme S2. (a) aq. NaHCO3, acryloyl chloride, dioxane, 0 oC to 25 oC, 83%. (b) (i) PPh3 
polystyrene beads, THF, 37 oC, 24 h; (ii) 10:1 THF: H2O, 37 oC, 48 h; (iii) ANB-NOS, Et3N, DMF 
(33%, three steps). 
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2.  Supporting Figure 
 
 
 
Figure S1. Chemoenzymatic strategy for the detection of Fucα(1-2)Gal glycans. Exogenous 
addition of the glycosyltransferase BgtA and UDP-GalNAz will covalently tag Fucα(1-2)Gal 
sugars with an azido functionality, which can be labeled with reporter groups such as 
fluorescent dyes using azide-alkyne [3+2] cycloaddition chemistry. 
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Figure S2. Expression of Fucα(1-2)Gal-containing glycoproteins in the rat brain cortex.  
Glycoproteins were detected using fluorescein-conjugated UEAI. 
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Figure S3. Coimmunostaining of WT and FUT2-/- cortical neuronal cultures for SV2a (green) 
and syt1 (red).  Arrowheads indicate colocalized puncta (yellow) of SV2a and syt along the 
neuronal processes. Scale bar = 10 µm.  
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A)                                                              B)  
	               
	   
 
Figure S4. SV2a is not modified by Fucα(1-2)Gal glycans . SV2a was immunoprecipitated from 
the rat brain cortex, and the immunoprecipitated protein was analyzed by A) Western blotting 
using an anti-Sv2a antibody or B) lectin blotting using biotinylated-UEAI followed by 
streptavidin conjugated to horseradish peroxidase to detect Fucα(1-2)Gal glycans. Inp, lysate 
input into IP; 1 and 2 indicate duplicate samples. 
 
 
 
 
 
1 
SV2a 
2 Inp 
______"IP: SV2a 
150 - 
  37 - 
 75 - 
  50 - 
______"
Fucα(1-2)Gal 
1 2 Inp 
IP: SV2a 
150 - 
  37 - 
 75 - 
  50 - 
	   S7	  
3.  Supporting Table 
Table S1. Fucα(1-2)Gal Glycan-Binding Proteins Identified from Rat Synaptosomal and Membrane Fractionsa 
	  
a Proteins from Sprague Dawley rats were captured using glycopolymer 10 
b The number of full tryptic unique peptides and their coverage were identified from a reversed database searching strategy. See 
Materials and Methods for procedures and analysis criteria. 
 
Cellular Adhesion
Ctnna2 IPI00364916.2 8 13.6 100000 Cellular differentation
Ctnnd1 IPI00359491.3 6 10 105000 Cellular recognition
Cellular Signalling
Dclk1 (Ania 4) IPI00778626.1 13 23.8 84000 Neuronal migration
Centg3 IPI00358128.3 6 9 102000 Signal transduction
Crmp1 IPI00561065.2 9 16 74000 Axonal guidance
Crimp4 IPI00203250.1  7 13.6 74000 Neurite outgrowth
Gαo IPI00231505.5 7 22.3 40000 Signal transduction
Gnaq IPI00230868.4 6 20.1 42000 Signal transduction
Pkcε IPI00551781.4 10 17.8 83000 Phosphorylation
Cytoskeletal-Associated Proteins
Ckap5 IPI00764313.1 9 5.9 197000 Microtubule elongation
Cyln2 IPI00195929.1 10 12.3 111000 Microtubule associated transport
Dync1h1 IPI00327630.1 54 13.5 532000 Dynein motor protein
Kif5b  IPI00364904.2 10 15.1 110000 Kinesin motor protein
Kif5c IPI00193402.4 16 21.2 109000 Kinesin motor protein
LOC362587 similar to Macf1 IPI00359003.4 6 1 831000 Actin regulation
LOC367171 similar to Map4 IPI00393975.2 8 10.4 110000 Microtubule assembly
LOC363309 similar to Tbcd IPI00765967.1 6 5.6 134000 Microtubule regulation
Map2 IPI00206171.1  10 7.1 202000 Cytoskelatal organization
Cellular Metabolism
Aco2 IPI00421539.3 8 13.1 85000 Mitochondrial metabolism
Cad IPI00365582.3  6 3.1 243000 Enzymatic biosynthesis
Fasn IPI00200661.1 21 11.1 273000 Lipid biosynthesis
Hk1 IPI00202543.1 10 13 102000 Mitochondrial metabolism
Immt IPI00364895.4 7 12.4 82000 Mitochondrial  homeostasis
LOC360975 similar to Odo1 IPI00215093.1 13 17.9 116000 Mitochondrial metabolism
Phgdh IPI00475835.3 7 16.9 56000 Enzymatic biosynthesis
Prss15 IPI00205076.1 10 12.9 106000 Mitochondrial proteases
Uspx9 IPI00204923.4 11 5.4 291000 Ubiquitin Hydrolases
Protein Synthesis
Aars IPI00363563.3 8 11.5 107000 Translation
Cand1 IPI00205466.1 8 7.1 136000 Transcription
Ddx1 IPI00555314.1 8 12.8 82000 Transcription
Lrpprc Leucine rich protein 157 IPI00360075.2 12 10.7 157000 Transcription
Nars IPI00565217.3 7 15.2 64000 Translation
Tufm IPI00371236.3 7 19.7 50000 Translation
Protein Trafficking
Dctn1 IPI00196703.1 8 7.2 142000 Retrograde vesicle transport
Hspcb IPI00471584.7 13 18.9 83000 Chaperone for protein folding
Hspd1 IPI00339148.2 12 33 61000 Chaperone for mitochondrial protein
LOC315676 similar to Dmx-like 2 IPI00369671.3 7 3.1 344000 Synaptic vesicle scaffolding
Sv2a IPI00208115.4 6 10.8 83000 Neurotransmitter release
Syn2 IPI00210036.1 6 17.1 63000 Neurotransmitter release
Vac14 IPI00230981.1 7 11.6 88000 Endosome regulation
Vps35 IPI00363493.2 6 9.6 92000 Retrograde protein transport
Transporters
Atp5a1 IPI00396910.1 10 24.6 60000 ADP/ATP biosynthesis
Gria2 IPI00780113.1 6 7.5 103000 Glutamate Receptor
Slc25a4 IPI00231927.11 8 29.9 33000 ADP/ATP Translocase
FunctionUnique   PeptidesbProtein
Accession 
Number % Coverage
b MW       
(Da)
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4.  Experimental Methods 
 
4-1. Material and Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under an argon 
atmosphere, using anhydrous solvents. Solvents were dried by passage through an activated 
alumina column under argon. All other commercially obtained reagents were used as received 
unless otherwise noted. Thin layer chromatography (TLC) was performed using E. Merck silica 
gel 60 F254 precoated plates (0.25 mm). Visualization of the developed chromatogram was 
performed by UV, p-anisaldehyde or ninhydrin stain as necessary. ICN silica gel (particle size 
0.032 - 0.063 mm) was used for flash chromatography. Gel filtration chromatography (Sephadex 
LH-20, and G-25 ultrafine) was used in order to achieve purification of the final products. 1H 
NMR spectra were recorded on Varian Inova 500 (500 MHz) and 600 (600 MHz) spectrometers 
and are reported in parts per million (δ) relative to CDCl3 (7.26 ppm), CD3OD (4.87 ppm) or D2O 
(4.80 ppm). Data for 1H are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d 
= doublet, t = triplet, q = quartet, m = multiplet), coupling constant in Hz, and integration. 13C 
NMR spectra were recorded on a Varian Inova 500 (125 MHz) spectrometer and are reported in 
terms of chemical shift. High-resolution mass spectra were obtained by the Caltech Mass 
Spectral Facility using a	  Waters LCT Premier XE high-resolution mass spectrometer.   
Gel Permeation Chromatography (GPC) was carried out in 100 mM NaNO3 and 200 ppm NaN3 
in water using an OHpak SB – 804 HQ column (Shodex), which was connected in series with a 
miniDAWN TREOS MALLS detector and Optilab rEX differential refractometer (both from Wyatt 
Technology). The dn/dc values were obtained for each injection assuming 100% mass elution 
from the column using dextran (40K) as a calibration standard to confirm complete mass 
recovery. 
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4-2. Synthetic Procedures 
Phenyl 3,4,6-tri-O-acetyl-2-O-(methyl 2,3,4-tri-O-acetyl-α-L-fucopyranosyl)-1-thio-D-
galactopyranoside (6). A mixture of 51 (510 mg, 0.98 mmol), (phenylthio)trimethylsilane (0.77 
mL, 3.9 mmol) and zinc iodide (1.3 g, 3.9 mmol) in CH2Cl2 (1.0 mL) was stirred overnight at rt.2 
Following complete consumption of the starting material, the mixture was diluted with EtOAc 
and washed successfully with aq. NaHCO3, H2O and brine. The organic extract was dried over 
Na2SO4 and concentrated in vacuo.  The resulting residue was dissolved in dry THF (2.8 mL), 
and tetrabutylammonium fluoride in THF (2.0 mL of a 1M solution) was added to the solution. 
After 1 h, the solvent was removed in vacuo, and the residue was redissolved in EtOAc, washed 
with H2O, aq. NaHCO3, and brine. The organic layer was dried over Na2SO4 and concentrated to 
afford the crude thioglycoside. To a solution of this thioglycoside in dry pyridine (9.6 mL, 120 
mmol) was added a catalytic amount of DMAP (150 mg, 1.2 mmol) and acetic anhydride (6.1 
mL, 64 mmol). The reaction mixture was stirred at rt overnight, then diluted with EtOAc and 
washed successively with aq. CuSO4, aq. NaHCO3, H2O and brine. The organic extract was 
dried over Na2SO4 and concentrated in vacuo.  Purification by silica gel flash chromatography 
(3:2 Hex:EtOAc) afforded 7 (360 mg, 55%) as a white solid. 1H NMR (500 MHz, CDCl3): δ 7.48 
(d, J = 7.3 Hz, 2H), 7.36 – 7.27 (m, 3H), 5.69 (d, J = 5.7 Hz, 1H), 5.45 (d, J = 3.1 Hz, 1H), 5.34 
(d, J = 3.2 Hz, 1H), 5.30 (d, J = 3.7 Hz, 2H), 5.21 (dd, J = 10.6, 3.4 Hz, 1H), 5.03 (dd, J = 10.7, 
3.9 Hz, 1H), 4.73 (t, J = 6.5 Hz, 1H), 4.36 (q, J = 6.5 Hz, 1H), 4.29 (dd, J = 10.6, 5.7 Hz, 1H), 
4.07 (t, J = 6.4 Hz, 2H), 2.15 (s, 3H), 2.14 (s, 3H), 2.04 (s, 3H), 1.99 (s, 6H), 1.96 (s, 3H), 1.00 
(d, J = 6.5 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 170.69, 170.65, 170.56, 170.27, 170.03, 
169.97, 133.22, 131.70 (2C), 129.32 (2C), 127.78, 98.21, 87.81, 73.15, 70.99, 70.09, 68.16 
(2C), 67.89, 67.35, 65.87, 61.83, 20.92, 20.88, 20.84 (2C), 20.81, 20.80, 16.03. HRMS m/z 
Calculated for C30H38O15S [M]+: 670.1931. Found: 670.1941. 
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3-Azidopropyl-3,4,6-tri-O-acetyl-2-O-(methyl 2,3,4-tri-O-acetyl-α-L-fucopyranosyl)-D-
galactopyranoside (7). The following modified procedure was adapted from Kanie et al.3 
Compound 6 (360 mg, 0.54 mmol) and 3-azido-1-propanol (75 µL, 0.81 mmol) was azeotroped 
with toluene, dissolved in acetonitrile with 4Å molecular sieves, and cooled to -20 oC. N-
Iodosuccinimide (190 mg, 0.81 mmol) was added, and the mixture was allowed to stir for 15 
min. Silver triflate (210 mg, 0.81 mmol) was then added, and the mixture was allowed to warm 
to rt and stirred for 1 h. After the reaction was complete, the reaction mixture was diluted with 
EtOAc and washed successively with saturated aq. Na2SO3, aq. NaHCO3, and brine. The 
organic extract was dried over MgSO4 and concentrated in vacuo. The crude product was 
purified by silica gel flash chromatography (3:2 Hex:EtOAc) to afford 7 (230 mg, 64%) as a pale-
yellow solid.  1H NMR (500 MHz, CDCl3):  δ 5.39 (d, J = 3.9 Hz, 1H), 5.35 – 5.25 (m, 3H), 5.05 – 
4.98 (m, 2H), 4.54 – 4.44 (m, 2H), 4.18 (dd, J = 11.2, 6.5 Hz, 1H), 4.10 (dd, J = 11.3, 6.9 Hz, 
1H), 4.01 – 3.85 (m, 3H), 3.68 (dt, J = 9.9, 6.3 Hz, 1H), 3.43 (t, J = 6.6 Hz, 2H), 2.16 (s, 3H), 
2.13 (s, 3H), 2.05 (s, 3H), 2.01 (s, 3H), 1.99 (d, J = 3.4 Hz, 6H), 1.93 – 1.86 (m, 2H), 1.13 (d, J = 
6.5 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 170.78, 170.73, 170.54, 170.41 (2C), 170.20, 
101.75, 95.85, 73.83, 71.91, 71.25, 70.63, 68.33, 67.73, 67.31, 67.02, 64.77, 61.38, 48.28, 
29.44, 20.88, 20.84 (3C), 20.80, 20.77, 15.90. HRMS m/z Calculated for C27H39O16Na [M+Na]+: 
684.2228. Found: 684.2228. 
 
3-N-Acryloyl-aminopropyl-3,4,6-tri-O-acetyl-2-O-(methyl 2,3,4-tri-O-acetyl-α-L-fucopyra-
nosyl)-D-galactopyranoside (8). A suspension of 7 (200 mg, 0.31 mmol) and Pd/C (20% by 
wt) in dry EtOAc (3.1 mL) was charged with H2 gas for 3.5 h in the presence of a catalytic 
amount of triethylamine. The reaction mixture was diluted with EtOAc and filtered through celite. 
The filtrate was concentrated in vacuo, and the crude material was dissolved in dioxane (3.0 
mL) before the addition of aq. NaHCO3 (33 mg in 2.9 mL H2O, 0.39 mmol). The reaction mixture 
was cooled to 0 oC, stirred for 15 min, and acryolyl chloride (37 µL, 0.45 mmol) was added 
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dropwise. The reaction was allowed to warm to rt overnight with minimal exposure to light, then 
diluted with EtOAc and washed with H2O. The organic layer was concentrated in vacuo, and the 
crude product was purified by silica gel flash chromatography (1:9 MeOH:CH2Cl2) to afford 8 as 
colorless oil (120 mg, 57%).  1H NMR (500 MHz, CDCl3): δ 6.30 (dd, J = 17.0, 1.4 Hz, 1H), 6.14 
(dd, J = 17.0, 10.3 Hz, 1H), 5.64 (dd, J = 10.3, 1.4 Hz, 1H), 5.40 (d, J = 3.8 Hz, 1H), 5.32 – 5.27 
(m, 3H), 5.04 – 4.97 (m, 2H), 4.54 (q, J = 6.6 Hz, 1H), 4.47 (d, J = 7.8 Hz, 1H), 4.18 (dd, J = 
11.3, 6.7 Hz, 1H), 4.11 (dd, J = 12.4, 6.9 Hz, 1H), 3.97 – 3.86 (m, 3H), 3.76 – 3.69 (m, 1H), 3.44 
(q, J = 6.6 Hz, 2H), 2.16 (s, 3H), 2.14 (s, 3H), 2.05 (d, J = 2.1 Hz, 3H), 2.01 (s, 3H), 2.00 (s, 3H), 
1.99 (s, 3H), 1.89 (td, J = 13.1, 6.6 Hz, 2H), 1.13 (d, J = 6.5 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): δ 170.71, 170.70, 170.53, 170.47, 170.32, 170.30, 165.86, 131.02, 126.35, 101.74, 
95.67, 73.72, 71.62, 71.15, 70.77, 68.24, 67.98, 67.83, 67.40, 64.79, 61.44, 37.03, 29.69, 20.88, 
20.81, 20.78 (2C), 20.73 (2C), 15.83. HRMS m/z Calculated for C30H44NO17 [M+H]+: 690.2609. 
Found: 690.2629. 
 
3-N-Acryloyl-aminopropyl-2-O-(α-L-fucopyranosyl)-D-galactopyranoside (1). 
To a solution of 8 (120 mg, 0.17 mmol) in MeOH (1.1 mL) was added 0.5 M NaOMe (100 µL, 
0.052 mmol). The reaction mixture was stirred at rt for 1 h, then neutralized to pH ~7 by the 
addition of Dowex 50W-X4-200 (H+), and the resin was filtered off. The filtrate was concentrated 
in vacuo and purified with gel filtration chromatography (Sephadex LH-20) to obtain 
disaccharide monomer 1 as a white foam (68 mg, 90%).  1H NMR (500 MHz, D2O): δ 6.25 (dd, J 
= 17.1, 10.2 Hz, 1H), 6.17 (dd, J = 17.1, 1.3 Hz, 1H), 5.74 (dd, J = 10.2, 1.3 Hz, 1H), 5.23 (d, J = 
3.9 Hz, 1H), 4.48 (d, J = 7.9 Hz, 1H), 4.29 (q, J = 6.5 Hz, 1H), 3.95 (dt, J = 10.2, 6.8 Hz, 1H), 
3.89 (d, J = 3.3 Hz, 1H), 3.84 (dt, J = 9.5, 2.7 Hz, 2H), 3.81 – 3.71 (m, 5H), 3.67 (dd, J = 7.7, 4.5 
Hz, 1H), 3.58 (dd, J = 9.5, 7.9 Hz, 1H), 3.35 (dd, J = 11.3, 6.7 Hz, 2H), 1.91 – 1.84 (m, 2H), 1.19 
(d, J = 6.6 Hz, 3H). 13C NMR (125 MHz, D2O): δ 168.68, 130.08, 127.30, 101.68, 99.67, 77.09, 
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75.14, 73.83, 72.01, 69.64, 69.09, 68.48, 67.87, 66.98, 61.12, 36.57, 28.70, 15.51. HRMS m/z 
Calculated for C18H31NO11Na [M+Na]+: 460.1795. Found: 460.1781. 
 
3-N-Acryloyl-aminopropyl azide (12). To a solution of 3-azidopropylamine (870 mg, 8.7 mmol) 
in dioxane (20 mL) was added aq. NHCO3 (950 mg in 12 mL H2O, 11 mmol). The reaction 
mixture was cooled to 0 oC and stirred for 15 min. Acrylolyl chloride (1.1 mL, 13 mmol) was then 
added dropwise, and the reaction mixture was warmed to rt while minimizing exposure to light. 
After 2 h, the mixture was diluted with EtOAc, washed with H2O, and the organic layer was 
concentrated in vacuo. The crude product was purified by silica gel flash chromatography (1:1 
Hex:EtOAc) to afford 12 as a colorless oil (1.1 g, 83%).  1H NMR (500 MHz, CDCl3): δ 6.29 (dd, 
J = 17.0, 1.3 Hz, 1H), 6.08 (dd, J = 17.0, 10.3 Hz, 1H), 5.66 (dd, J = 10.3, 1.3 Hz, 1H), 3.44 (dd, 
J = 13.0, 6.5 Hz, 2H), 3.40 (t, J = 6.6 Hz, 2H), 1.88 – 1.80 (m, 2H). 13C NMR (125 MHz, CDCl3): 
δ 165.84, 130.77, 126.80, 49.52, 37.36, 28.87. HRMS m/z Calculated for C6H10N4O [M]+: 
154.0855. Found: 154.0842. 
 
3-N-Acryloyl-aminopropyl-2-nitrophenylazide (3). The following procedure was modified from 
Lindsley et al. and Hemming et al.4 Triphenylphosphine polystyrene resin (Novabiochem) was 
first equilibrated by washing successively with THF, CH2Cl2 and MeOH. After drying in vacuo, a 
suspension of the resin (3.4 g, 3.4 mmol) and 12 (530 mg, 3.4 mmol) in THF (21 mL) was gently 
shaken at 37 oC for 24 h. The mixture was filtered, and the residual beads were washed 
successively with THF, CH2Cl2 and MeOH. After drying in vacuo, the resin was resuspended in 
10:1 THF/H2O (15 mL) and gently shaken at 37 oC for 48 h. The filtrate was collected, and the 
resin was washed with CH2Cl2 and MeOH. The filtrate and the washes were combined and 
concentrated in vacuo to afford the amine intermediate (190 mg, 43%). To a solution of the 
amine in dry DMF (7.5 mL) was added Et3N (0.11 mL, 0.79 mmol) and N-(5-azido-2-
nitrobenzoyloxy)-succinimide (ANB-NOS, Pierce; 200 mg, 0.55 mmol). The reaction was 
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allowed to stir overnight in the dark, concentrated in vacuo, and the crude product was purified 
by silica gel flash chromatography (10:1 EtOAc:MeOH) to afford nitrophenylazide monomer 3 as 
a pale yellow solid (69 mg, 33 %).  1H NMR (500 MHz, CDCl3): δ 8.13 (d, J = 8.7 Hz, 1H), 7.15-
7.11 (m, 2H), 6.23 (dd, J = 17.0, 1.3 Hz, 1H), 6.10 (dd, J = 16.9, 10.2 Hz, 1H), 5.66 (dd, J = 
10.2, 1.3 Hz, 1H), 3.54 – 3.45 (m, 4H), 1.89 – 1.81 (m, 2H). 13C NMR (125 MHz, CDCl3): δ 
166.93, 166.33, 146.52, 142.34, 135.78, 130.58, 127.16, 127.07, 120.13, 119.13, 36.51, 36.25, 
29.41. HRMS m/z Calculated for C13H15N6O4 [M+H]+: 319.1155. Found: 319.1154. 
 
Polymerization reactions. The polymerization procedure was adapted from Hou et al.5 In a 
typical experiment, 4-aminobenzyl-biotinylamide 46 (17 mg, 46 µmol) was dissolved in degassed 
1:1 H2O/THF (0.8 mL) and reacted with HBF4 (8.7 µL of a 50 wt% aq. solution, 69 µmol) at 0 oC 
under an Ar atmosphere. The diazonium salt was generated by the addition of NaNO2 (3.9 mg, 
55 µmol) into the reaction mixture. After 30 min, a degassed mixture of disaccharide monomer 1 
(75 mg, 170 µmol), nitrophenylazide monomer 3 (18 mg, 57 µmol), acrylamide (49 mg, 690 
µmol), and NaOCN (15 mg, 220 µmol) in 1:1 H2O/THF (1.2 mL) was introduced to the 
diazonium salt, and the reaction mixture was heated to 60 oC for 16 h. The resulting mixture was 
dialyzed (3000 MWCO) at 4 oC against H2O for 48 h, purified by gel filtration chromatography 
(G-25), and lyophilized to afford the desired polymer as fluffy powder. No further purification was 
necessary following dialysis, as indicated by the absence of signal for vinyl protons in the 
purified polymer solutions.  
  The number of glycosyl units incorporated into the polymer (Table1, x) was calculated by 
comparing the integrals of the methyl peaks of fucose (1.24 ppm, 3H) and those of the phenyl 
group of the biotin handle (7.18 ppm, 4H). The number of nitrophenylazide crosslinker units 
(Table1, y) was calculated by comparing the integrals of the phenyl proton peaks (8.27 ppm, 
3H) and those of the phenyl group of the biotin handle. The number of the 3-hydroxylpropyl 
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units (Table1, z) was calculated by comparing the integrals of the methylene proton (3.63 ppm, 
2H) and those of the phenyl group of the biotin handle. 
 
FucGal polymer (9). Polymer 9 was prepared using the above procedure without 
nitrophenylazide monomer 3 to yield an orange fluffy powder (42%). Mn (SEC) = 26300.  PDI 
(SEC) = 1.17. 1H NMR (500 MHz, D2O): δ 7.18 (d, J = 15.5 Hz, 5H), 5.24 (s, 11H), 5.11 – 5.01 
(m, 5H), 4.55 – 4.26 (m, 32H), 4.13 – 3.51 (m, 186H), 3.48 – 3.12 (m, 38H), 2.43 – 2.04 (m, 
229H), 1.91 – 1.44 (m, 500H), 1.30 – 1.15 (m, 58H). 
 
FucGal crosslinker polymer (10). Polymer 10 was prepared using the above procedure to 
yield a light yellow fluffy powder (20% yield). Mn (SEC) = 23900. PDI (SEC) = 1.22. 1H NMR 
(500 MHz, D2O): δ 8.27 – 7.95 (m, 28H), 7.18 (d, J = 16.3 Hz, 6H), 5.24 (s, 25H), 5.12 – 4.99 
(m, 18H), 4.55 – 4.25 (m, 58H), 4.12 – 3.49 (m, 374H), 3.42 – 3.12 (m, 80H), 2.44 – 2.00 (m, 
159H), 1.89 – 1.46 (m, 338H), 1.24 – 1.14 (m, 91H). 
 
Control crosslinker polymer (11). Polymer 11 was prepared using the above procedure, but 
substituting 1 with 2, to yield a white fluffy powder (21% yield). Mn (SEC) = 23000.  PDI (SEC) = 
1.17. 1H NMR (500 MHz, D2O): δ 8.29 – 7.90 (m, 20H), 7.18 (d, J = 16.1 Hz, 5H), 3.63 (s, 85H), 
3.24 (s, 98H), 2.46 – 1.94 (m, 213H), 1.70 (d, J = 54.2 Hz, 477H). 
 
  
	   S15	  
4-3.  Biological Procedures 
 
Animals, Tissue Isolation and Synaptosome Preparation. Sprague Dawley rats and 
C57BL/6 wild type, FUT1-/- and FUT2-/- mice were maintained in accordance with proper 
Institute of Animal Care and Use Committee (IACUC) procedures. Adult mice (3-4 months of 
age) and postnatal day 3 (P3) pups were anesthetized with CO2 and dissected to remove the 
cortex and hippocampus. Synaptosomes (P2’) were prepared from P3 rat pups by using a 
sucrose density gradient as previously described7 and dissolved in lectin binding buffer (100 
mM Tris pH 7.5, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 0.5% NP-40, and 0.2% sodium 
deoxycholate supplemented with EDTA-free Complete protease inhibitors (Roche)). To prepare 
cortical membrane fractions, cortices from P3 rat pups were extracted and fractionated using 
the Qproteome Cell Compartment Kit (Qiagen) to give a final protein concentration of 5 mg/mL. 
 
UEAI Lectin Enrichment and Photocrosslinking Capture. Fluorescein-conjugated UEAI  
(Vector Laboratories; 100 µg) was incubated with polymer 10 or 11 (50 µM) in lectin binding 
buffer with gentle end-over-end mixing at 37 oC for 3 h in the dark. The samples were irradiated 
with UV light at 365 nm (Blak-Ray B100 AP, Upland) for 15 min at 4 oC if indicated and mixed 
further at rt for 45 min in the dark. The samples were diluted with binding buffer to a final 
concentration of 1 mg/mL and incubated with pre-treated (blocked with 0.1% fish gelatin) 
streptavidin agarose resin (Pierce) at 4 oC for 2 h. The resin was washed twice with 10 column 
volumes each of low salt buffer (0.1 M Na2HPO4 pH 7.5, 0.15 M NaCl, 1% Triton X-100, 0.5% 
sodium deoxycholate, 0.1% SDS), twice with 10 column volumes each of high salt buffer (0.1 M 
Na2HPO4 pH 7.5, 0.5 M NaCl, 0.2% Triton X-100), and once with 10 column volumes of 50 mM 
Tris•HCl pH 7.4. Captured protein was eluted in boiling sample buffer (50 mM Tris pH 6.8, 2.5% 
SDS, 2 mM DTT, 10% glycerol, 2 mM biotin) for 5 min. The sample was resolved on a NuPAGE 
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4-12% Bis-Tris gel (Invitrogen), transferred to polyvinylidene difluoride (PVDF) membrane 
(Millipore) and visualized using a Typhoon Scanner (GE Healthcare).  
 
Fucα(1-2)Gal Glycan-Binding Protein Enrichment and Photocrosslinking Capture. Brain 
lysates from the synaptosomal and membrane fractions (1.2 mg) were pre-incubated with 
polymer 11 (35 µM) in lectin binding buffer and pre-cleared against high capacity streptavidin 
agarose resin (Pierce) with gentle end-over-end mixing for 2 h in the dark. After centrifugation at 
1000 x g for 3 min, the supernatants were incubated with polymer 10 or 11 (75 µM) in lectin 
binding buffer with gentle end-over-end mixing at 37 oC for 3 h in the dark. The samples were 
irradiated with UV light at 365 nm for 15 min at 4 oC and mixed further at rt for 45 min in the 
dark. The samples were diluted with binding buffer to a final concentration of 1 mg/mL and 
incubated with pre-treated (blocked with 0.1% fish gelatin) high capacity streptavidin agarose 
resin at 4 oC for 4 h. The resin was then washed twice with 10 column volumes each of low salt 
buffer, twice with 10 column volumes each of high salt buffer, once with 20 column volumes of 4 
M urea + 1% SDS and once with 10 column volumes of 50 mM Tris•HCl pH 7.4. Captured 
protein was eluted in boiling sample buffer for 5 min and subsequently resolved by 10% SDS-
PAGE for LC-MS analysis. 
 
Silver Staining, In-Gel Digestion, and LC-MS Analysis. All silver staining reagents were 
prepared fresh before they were used. The staining and destaining, in-gel tryptic digests, and 
peptide extractions were performed as described previously.8 NanoLC-MS of in-gel tryptic 
digests was performed on a Thermo Fisher LTQ XL linear ion trap mass spectrometer using a 
modified vented column setup and data-dependent scanning.9 Samples were loaded onto a 360 
µm x 100 µm precolumn (2 cm, 5 µm Monitor C18) and desalted before the precolumn was 
placed in-line with the analytical column. Peptides were then eluted with a linear gradient from 0 
to 40% B over 30 min (A, 0.1 M aq. HOAc; B, 0.1 M HOAc in CH3CN), with a flow rate of 
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approximately 250 nL/min, and using a 360 µm x 75 µm self-packed column with an integrated 
electrospray emitter (10 cm, 5 µm Monitor C18). For data-dependent experiments, the mass 
spectrometer was programmed to record a full-scan ESI mass spectrum (m/z 400-2000), 
followed by five data-dependent MS/MS scans in the ion trap (relative collision energy of 35%, 
3.5 Da isolation window). Dynamic exclusion parameters were set as follows: repeat count=1, 
repeat duration=15 s, and exclusion duration=30 s.  
 
MS/MS spectra were searched against a rat subset of the European Bioinformatics Institute-
International Protein Index (EBI-IPI) database (downloaded August 1, 2007), with an appended 
reversed database using Sequest 3.0. A fixed modification of Cys (+57), a variable modification 
of Met (+16), and trypsin cleavage were specified. Mass tolerances of 3.0 Da for the parent and 
0.8 Da for the fragment ions were employed. Search results were compiled and filtered in 
Scaffold 2.0 (Proteome Software, Inc., Portland, OR). Peptide identifications were accepted if 
they could be established at ≥95.0% probability, as specified by the Peptide Prophet 
algorithm.10 Protein identifications were accepted if they could be established at ≥99.0% 
probability (as specified by the Protein Prophet algorithm)11 and were based on at least three 
unique peptide identifications. To be listed in Table 1, proteins had to be identified as specified 
both in at least two of the three synaptosome and/or membrane fractions from the polymer 10 
samples, as well as on the basis of six unique peptides identified from among the various 
fractions.  By contrast, proteins were eliminated as non-specific if even a single peptide was 
also identified in any of the polymer 11 samples.  Using these highly stringent filtering criteria, 
44 candidate GBPs were identified from six independent runs (three synaptosome and 
membrane fractions). 
 
Protein Expression and Purification. DCLK1 (DCAMKL1) was expressed and purified from E. 
coli BL21(DE3) cells harboring the recombinant plasmid vector pET28a-DCLK1-His as 
previously described.12 SV2a was expressed and purified from HEK293 cells transfected with 
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plasmid vector SV2a-FLAG-pIRES2 as previously described.13 GαO protein was kindly provided 
by Dr. Tohru Kozasa (University of Illinois, Chicago). PKCε protein was purchased from 
ProspecBio.  
 
Binding Validation of Lectin Candidates to Fucα(1-2)Gal by ELLA. Nunc Maxisorp 384-well 
plates were coated overnight at 4 oC with lectin (50 ng/well) in carbonate buffer (50 µL, 50 mM, 
pH 9.0). The wells were then washed with washing buffer (3 x 100 µL, 50 mM Tris-HCl pH 7.4, 
150 mM NaCl containing 0.03% Tween 20). The washing procedure was repeated after each 
incubation throughout the assay. After washing, the wells were filled with serial dilutions of 
biotinylated polymers (Fucα(1-2)Gal, Galα(1-2)Gal and control (-OH) polymer, 25 µL/well, 
GlycoTech) in binding buffer (PBS, 1 mM CaCl2, 4 mM MgCl2) and incubated at rt for 2.5 h. The 
wells were washed and blocked with 10% Fetal Bovine Serum (FBS; 80 µL) at 37 oC for 1 h.  
The plates were then incubated with horseradish peroxidase-conjugated streptavidin (Pierce; 
1∶40000) at rt for 1 h, developed with 3,3’,5,5-tetramethylbenzidine substrate (TMB; Pierce) and 
quenched with 2 M H2SO4. Absorbances were measured at 450 nm using a PerkinElmer Victor 
plate reader and were fitted to a linear regression analysis using KaleidaGraph (version 4.1.2). 
Experiments were performed in triplicate, and data represent the mean ± SEM. 
 
Chemoenzymatic Labeling of Cell Lysates. This procedure was adapted from Chaubard et 
al.14  The cortices of adult C57BL/6, FUT1-/- and FUT2-/- mice were dissected on ice and lysed 
in boiling 1% SDS (5 volumes/weight) with sonication until the mixture was homogeneous. 
Protein was precipitated with methanol/chloroform/water. Briefly, protein was diluted to 200 µL 
and precipitated by sequential mixing with 600 µL of MeOH, 200 µL of CHCl3 and 450 µL H2O, 
after which the mixture was centrifuged at 23,000 x g for 15 min. Precipitated protein was 
washed with 450 µL of MeOH and centrifuged at 23,000 x g for 10 min. After the protein pellet 
was allowed to dry briefly, the pellet was re-dissolved at 5 mg/mL in 20 mM HEPES pH 7.9 
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containing 1% SDS, and diluted 5-fold into a buffer with the following final concentrations: 20 
mM HEPES pH 7.9, 50 mM NaCl, 2% NP-40, 5 mM MnCl2. UDP-GalNAz  (Invitrogen; 25 µM) 
and BgtA (0.16 mg/mL) were added, and the samples were incubated at 4 °C for 16-20 h. The 
labeled proteins were precipitated as above and resuspended in 50 mM Tris pH 7.4 containing 
1% SDS at 4 mg/mL. The resuspended proteins were subsequently reacted with 5-
carboxytetramethylrhodamine (TAMRA) alkyne (Invitrogen) per the Click-It™ TAMRA Protein 
Analysis Detection kit instructions (Invitrogen), except that EDTA-free Complete™ protease 
inhibitors were added during the reaction. Negative controls were performed under identical 
conditions except that BgtA was omitted from the labeling reaction. After the labeling reactions, 
protein was precipitated using methanol/chloroform/water as described above and re-dissolved 
in boiling 2% SDS. TAMRA-labeled proteins were resolved on a NuPAGE 4-12% Bis-Tris gel 
and transferred to PVDF membrane. The membrane was blocked with 5% milk (Biorad) in 
TBST (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.05% Tween 20) for 1 h at rt and immunoblotted 
with a rabbit anti-TAMRA antibody (Invitrogen; 1:1000) and a mouse anti-tubulin antibody 
(Sigma Aldrich 1:5000). Membranes were washed with TBST, incubated with the appropriate 
Alexa Fluor 680-conjugated (Invitrogen) or IR800-conjugated (Rockland) secondary antibody, 
and visualized using a LiCOR Odyssey Imaging System.  
 
Detection of Fucα(1-2)Gal Glycoproteins by UEAI Lectin Blotting. Cortical proteins 
precipitated from C57BL/6, FUT1-/- and FUT2-/- mice were resolved on a NuPAGE 4-12% Bis-
Tris gel and transferred to PVDF membrane. The membrane was blocked with 5% milk (Biorad) 
in PBST (PBS+ 0.05% Tween 20) at rt for 1 h and immunoblotted with fluorescein-conjugated 
UEAI (1:100) at rt for 1 h. The membrane was washed with TBST and visualized using a 
Typhoon Scanner. 
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Neuronal Cultures for Functional Assays. For biochemical assays, cortical neuronal cultures 
were prepared as previously described,15 except that neurons from E15-16 timed-pregnant 
C57BL/6, FUT1-/- or FUT2-/- mice were plated onto poly-DL-lysine-coated 6-well plates (BD 
Bioscience). Neurons were maintained for up to 10 days in vitro (DIV) in Neurobasal medium 
(NBM; Life Technologies) supplemented with 2 mM Glutamax-I and 2% B-27 (Invitrogen). For 
staining and imaging, hippocampal neurons were prepared as previously described,16 except 
that neurons from E15-16 timed-pregnant mice were plated on poly-DL-lysine-coated glass 
coverslips (Carolina Biological) at a density of 75 cells/mm2. Neurons were maintained for up to 
10 DIV in NBM supplemented with 2 mM Glutamax-I and 2% B-27.  
 
Assaying SV2a Distribution in Cortical Neurons. Cortical neuron cultures (C57BL/6 FUT1-/- 
and FUT2-/-, 10 DIV) were washed once with ice-cold PBS, gently scraped with trypsin and 
suspended in Dulbecco’s Modified Eagle Medium (DMEM; Life Technologies) supplemented 
with 10% FBS (Invitrogen) and then centrifuged for 10 min at 500 x g at 4 oC. Pellets were 
washed with cold PBS and fractionated using the Qproteome Cell Compartment Kit. The protein 
concentrations of the resulting membrane extracts were measured using the BCA assay 
(Pierce). Equal amounts of protein were resolved on a NuPAGE 4-12% Bis-Tris gel and 
transferred to PVDF membrane. The membrane was blocked with 5% milk, immunoblotted with 
a goat anti-SV2a (E-15, Santa Cruz; 1:200) or mouse anti-synaptophysin (Sigma Aldrich; 1:800) 
antibody and visualized using a LiCOR Odyssey Imaging System. SV2a distribution in the 
membranes of FUT1-/- and FUT2-/- neurons was expressed relative to the level in C57BL/6 
mice (n = 3-5) and was reported as the mean ± SEM. Statistical analysis was performed using 
the Student’s unpaired t-test to compare the SV2a level between FUT2-/- and C57BL/6 
neurons.  
 
Immunostaining and Quantification. Hippocampal neurons on coverslips were rinsed once 
with PBS, fixed with 4% paraformaldehyde (PFA)/ 4% sucrose at rt for 20 min, washed twice 
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with PBS, permeabilized with 0.3% TritonX-100 at rt for 5 min, and washed twice with PBST. 
Non-specific binding was blocked by incubating with 5% goat serum (GS) in PBST at 4 oC for 1 
h.  After rinsing twice with PBST, the cells were incubated with a rabbit anti-SV2a antibody 
(Synaptic Systems; 1:300) in 5% GS at rt for 2 h. Excess antibody was removed by washing five 
times with PBST, and the cells were incubated overnight with a mouse anti-synaptophysin 
antibody (Millipore; 1:300) in 5% GS at 4 oC.  After washing five times with PBST, the cells were 
treated with anti-rabbit IgG AlexaFluor 488 (Invitrogen; 1:1000) and anti-mouse IgG 
AlexaFluor568 (Invitrogen; 1:1000) antibodies in 5% GS at rt for 2 h. The coverslips were 
mounted onto glass slides and imaged using a LSM510 Meta confocal laser scanning 
microscope with a 100X 1.40 N.A oil immersion plan apochromat objective lens (Carl Zeiss 
MicroImaging, Inc.). All images were acquired blind to the experimental conditions. To minimize 
possible sources of bias, 7-10 neurons were randomly selected from 3 representative fields in 
each cover slip. Each genotype was analyzed from at least three independent experiment using 
three different mice (n=70-80 images). 
 
Images were analyzed blind to the experimental condition using NIH ImageJ software 
(http://rsbweb.nih.gov/ij/) using the JACoP Colocalization plugin, and colocalized puncta 
analysis was performed as previously described17 using the Colocalization Highlighter plugin. To 
determine the degree of colocalization between two proteins, each channel was set with the 
same threshold value, and the distinct puncta in each channel were overlaid to generate a 
colocalized region. Colocalized puncta (i.e. yellow pixel clusters) were defined as continuous 
pixel clusters between 0.5 – 11 µm in size and having an intensity at least 2-fold greater than 
each individual (red or green) channel in the adjacent dendrite. The number of colocalized 
puncta per unit area (puncta density) were manually counted and then normalized with respect 
to the WT sample. Statistical analyses were performed using the Student’s unpaired t-test, and 
the data were reported as the mean ± SEM. 
	   S22	  
Surface Biotinylation and SV2a Immunoprecipitation.  Cortical neuronal cultures (C56BL/7, 
FUT1-/- and FUT2-/-, 10 DIV) were washed once with ice-cold PBS, pH 8.0, and biotinylated by 
incubating with 0.5 mg/ml EZ-Link Sulfo-NHS-LC-LC-Biotin (Pierce) for 25 min at 4 oC with 
gentle shaking.18   Cultures were washed with PBS, pH 7.4, and incubated with 100 mM glycine 
for 15 min at 4 oC to quench the reaction.  Neurons were rinsed with ice-cold PBS, pH 7.4, and 
extracted in solubilization buffer (150 mM NaCl, 50 mM Tris-HCl, 1 mM EDTA, 1% NP-40 and 
protease inhibitor) for 1 h at 4 oC.  Insoluble material was removed by ultracentrifugation (19,000 
x g for 20 min), and the supernatants were subjected to immunoprecipitation by incubating with 
an anti-SV2a antibody (E-15, Santa Cruz) overnight at 4 oC.  The samples were diluted with 
solubilization buffer to a final concentration of 1 mg/mL and then were incubated with pre-
treated (blocked with 0.1% fish gelatin) protein A/G sepharose beads (ThermoFisher) at 4 oC for 
2 h.  The resin was washed three times with 10 column volumes of solubilization buffer, and the 
captured protein was eluted with loading dye without boiling.   Equal amount of protein were 
resolved on a NuPAGE 4-12% Bis-Tris gel and transferred to PVDF membrane.  The 
membrane was blocked in 5% milk and immunoblotted with a rabbit anti-SV2a antibody (1:300, 
Synaptic Systems) for total immunoprecipitated SV2a and streptavidin-HRP (1:1000, Pierce) for 
biotinylated SV2a.  Labeled bands were visualized and quantified using a LiCOR Odyssey 
Imaging System.  The proportion of SV2a on the plasma membrane of FUT2-/- neurons was 
expressed as the normalized intensity of biotinylated-SV2a signal to the total SV2a, and was 
reported relative to the control C57BL/6 level (n=4) as the mean ± SEM.  Statistical analysis was 
performed using the Student’s unpaired t-test to compare the SV2a level between FUT2-/- and 
C57BL/6 neurons. 
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4-4.  Representative 1H and 13C NMR Spectra 
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